Healshape
PrivateLast Round
Seed
Jun 28, 2022
Total Funding Raised
$6.3M
Company Overview
Healshape is a regenerative medicine company that develops 3D-bioprinted, personalized, and resorbable bioprostheses for soft tissue reconstruction.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healshape Comps
Public and private peers based on sector, stage, and business model.
Healshape Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 28, 2022 | ||||
| Grant | Jul 16, 2020 | ||||
| Accelerator | Jan 28, 2020 |
Key People
Founding team and executive leadership
Healshape Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Les Premières Auvergne-Rhône-Alpes | Accelerator |
| GO Capital | Seed |
| Angels Santé | Seed |
| Pulsalys | Accelerator |
| WinEquity | Seed |
| Crédit Agricole Création | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2024
Grew 17% QoQ, from 18 to 21 employees.
- Jun 28, 2022
$6.3M round led by Demea Sustainable Investment and GO Capital.
Healshape Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Healshape's valuation, stock price, and market status.
Firmographic Details
HeadquartersLyon
Employee Range25
Year Founded2020
Last FundingJun 28, 2022
